-
1
-
-
1842355502
-
The metabolism of aluminum
-
De Broe ME. Coburn JW, eds. Kluwer Academic, Dordrecht
-
Van de Vyver FL, D'Haese PC, De Broe ME. The metabolism of aluminum. In: De Broe ME. Coburn JW, eds. Aluminum and Renal Failure. Kluwer Academic, Dordrecht, 1990: 27-39
-
(1990)
Aluminum and Renal Failure
, pp. 27-39
-
-
Van De Vyver, F.L.1
D'Haese, P.C.2
De Broe, M.E.3
-
2
-
-
9444239899
-
Aluminum toxicity in renal failure
-
Maher JF, ed. Kluwer Academic, Dordrecht
-
Tomson CRV, Ward MK. Aluminum toxicity in renal failure. In: Maher JF, ed. Replacement of Renal Function by Dialysis. Kluwer Academic, Dordrecht, 1989, 1004-1017
-
(1989)
Replacement of Renal Function by Dialysis
, pp. 1004-1017
-
-
Tomson, C.R.V.1
Ward, M.K.2
-
3
-
-
0028158435
-
Cela n'arrive qu'aux autres
-
Simoes JC, Barata JD, D'Haese PC, Lamberts LV, de Broe ME. Cela n'arrive qu'aux autres. Nephrol Dial Transplant 1994; 9: 67-68
-
(1994)
Nephrol Dial Transplant
, vol.9
, pp. 67-68
-
-
Simoes, J.C.1
Barata, J.D.2
D'Haese, P.C.3
Lamberts, L.V.4
De Broe, M.E.5
-
4
-
-
0021796116
-
Measurement of aluminum in serum, blood, urine, and tissues of chronic hemodialyzed patients by electrothermal atomic absorption spectrometry
-
D'Haese PC, Van de Vyver FL, de Wolff FA, De Broe ME. Measurement of aluminum in serum, blood, urine, and tissues of chronic hemodialyzed patients by electrothermal atomic absorption spectrometry. Clin Chem 1985; 31: 24-29
-
(1985)
Clin Chem
, vol.31
, pp. 24-29
-
-
D'Haese, P.C.1
Van De Vyver, F.L.2
De Wolff, F.A.3
De Broe, M.E.4
-
5
-
-
9444271196
-
Side-effects of desferrioxamine in dialysis patients
-
Boelaert JR, de Locht M. Side-effects of desferrioxamine in dialysis patients. Nephrol Dial Transplant 1992; Suppl 1: 44-47
-
(1992)
Nephrol Dial Transplant
, Issue.1 SUPPL.
, pp. 44-47
-
-
Boelaert, J.R.1
De Locht, M.2
-
6
-
-
9444267216
-
Clinical and biochemical features of aluminum-related bone disease
-
Ihle BU, Becker GJ, Kincaid-Smith PS. Clinical and biochemical features of aluminum-related bone disease. Kidney Int 1986; suppl 18: S80-S86
-
(1986)
Kidney Int
, Issue.18 SUPPL.
-
-
Ihle, B.U.1
Becker, G.J.2
Kincaid-Smith, P.S.3
-
7
-
-
0343934747
-
Pathophysiologic mechanisms of aluminum toxicity: Aluminum-induced bone disease
-
De Broe ME, Coburn JW, eds. Kluwer Academic, Dordrecht
-
Goodman WG. Pathophysiologic mechanisms of aluminum toxicity: aluminum-induced bone disease. In: De Broe ME, Coburn JW, eds. Aluminum and Renal Failure, Kluwer Academic, Dordrecht, 1990: 27-39
-
(1990)
Aluminum and Renal Failure
, pp. 27-39
-
-
Goodman, W.G.1
-
8
-
-
0026558214
-
Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients
-
Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, Saiphoo C, Fenton S. Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients. Kidney Int 1992; 41: 1374-1382
-
(1992)
Kidney Int
, vol.41
, pp. 1374-1382
-
-
Pei, Y.1
Hercz, G.2
Greenwood, C.3
Sherrard, D.4
Segre, G.5
Manuel, A.6
Saiphoo, C.7
Fenton, S.8
-
9
-
-
0028849828
-
Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with: Aluminum-related bone disease/increased risk for aluminum toxicity aluminum overload
-
D'Haese PC, Couttenye M-M, Goodman WG, Lemoniatou E, Digenis P, Sotornik I, Fagalde A, Barsoum RS, Lamberts LV, De Broe ME. Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with: aluminum-related bone disease/increased risk for aluminum toxicity aluminum overload. Nephrol Dial Transplant 1995; 10: 1874-1884
-
(1995)
Nephrol Dial Transplant
, vol.10
, pp. 1874-1884
-
-
D'Haese, P.C.1
Couttenye, M.-M.2
Goodman, W.G.3
Lemoniatou, E.4
Digenis, P.5
Sotornik, I.6
Fagalde, A.7
Barsoum, R.S.8
Lamberts, L.V.9
De Broe, M.E.10
-
10
-
-
0020961051
-
Summary report of an international workshop on 'The role of biological monitoring in the prevention of aluminum toxicity in man: Aluminum analysis in biological fluids'
-
Savory J, Berlin A, Courtoux C, Yeoman B. Wills M. Summary report of an international workshop on 'The role of biological monitoring in the prevention of aluminum toxicity in man: aluminum analysis in biological fluids'. Ann Clin Lab Sci 1983; 13: 444-451
-
(1983)
Ann Clin Lab Sci
, vol.13
, pp. 444-451
-
-
Savory, J.1
Berlin, A.2
Courtoux, C.3
Yeoman, B.4
Wills, M.5
-
11
-
-
0025217636
-
Value of serum aluminum monitoring in dialysis patients; a multicentre study
-
D'Haese PC, Clement JP, Elseviers MM, Lamberts LV, Van de Vyver FL, De Broe ME. Value of serum aluminum monitoring in dialysis patients; a multicentre study. Nephrol Dial Transplant 1990; 5: 45-53
-
(1990)
Nephrol Dial Transplant
, vol.5
, pp. 45-53
-
-
D'Haese, P.C.1
Clement, J.P.2
Elseviers, M.M.3
Lamberts, L.V.4
Van De Vyver, F.L.5
De Broe, M.E.6
-
12
-
-
9444243975
-
Low serum aluminum (sAl) levels can be associated with a high body Al burden in iron (Fe)-overloaded dialysis (D) patients
-
abstract
-
Ostric V, Vrzic R, D'Haese PC, Bukvic D, Djukanovic L, Van Landeghem GF, Lamberts LV, De Broe ME. Low serum aluminum (sAl) levels can be associated with a high body Al burden in iron (Fe)-overloaded dialysis (D) patients. J Am Soc Nephrol 1994; 5: 469 (abstract)
-
(1994)
J Am Soc Nephrol
, vol.5
, pp. 469
-
-
Ostric, V.1
Vrzic, R.2
D'Haese, P.C.3
Bukvic, D.4
Djukanovic, L.5
Van Landeghem, G.F.6
Lamberts, L.V.7
De Broe, M.E.8
-
13
-
-
85047700469
-
Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients
-
Verpooten GA, D'Haese PC, Boelaert JR, Becaus I, Lamberts LV, De Broe ME. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients. Nephrol Dial Transplant 1992; 7: 931-938
-
(1992)
Nephrol Dial Transplant
, vol.7
, pp. 931-938
-
-
Verpooten, G.A.1
D'Haese, P.C.2
Boelaert, J.R.3
Becaus, I.4
Lamberts, L.V.5
De Broe, M.E.6
-
14
-
-
0022646202
-
Changes in bone histology after treatment with desferrioxamine
-
Ott SM, Andress DL, Nebeker HG, Milliner DS, Maloney NA, Coburn JW, Sherrard DJ. Changes in bone histology after treatment with desferrioxamine. Kidney Int 1986; 29: S108-S113
-
(1986)
Kidney Int
, vol.29
-
-
Ott, S.M.1
Andress, D.L.2
Nebeker, H.G.3
Milliner, D.S.4
Maloney, N.A.5
Coburn, J.W.6
Sherrard, D.J.7
-
15
-
-
0030045385
-
Low dose (5 mg/kg) desferrioxamine treatment in acutely aluminum-intoxicated haemodialysis patients using two drug administration schedules
-
in press
-
Barata JD, D'Haese PC, Pires C, Lamberts LV, Simoes J, De Broe ME. Low dose (5 mg/kg) desferrioxamine treatment in acutely aluminum-intoxicated haemodialysis patients using two drug administration schedules. Nephrol Dial Transplant 1996; in press
-
(1996)
Nephrol Dial Transplant
-
-
Barata, J.D.1
D'Haese, P.C.2
Pires, C.3
Lamberts, L.V.4
Simoes, J.5
De Broe, M.E.6
-
16
-
-
0026524469
-
Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis
-
Vasilakakis DM, D'Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Kidney Int 1992; 41: 1400-1407
-
(1992)
Kidney Int
, vol.41
, pp. 1400-1407
-
-
Vasilakakis, D.M.1
D'Haese, P.C.2
Lamberts, L.V.3
Lemoniatou, E.4
Digenis, P.N.5
De Broe, M.E.6
|